RICHMOND, British Columbia, Sept. 29, 2009 (GLOBE NEWSWIRE) -- Whispering Oaks International, Inc., d/b/a Biocurex (OTCBB:BOCX), announced today that it is making two presentations at the annual meeting of the International Society of Oncology and Biomarkers (ISOBM) being held this week in Amsterdam, The Netherlands. BioCurex's presentations address its RECAF cancer market test in combination with other currently used cancer markers: CA-125 for ovarian cancer and CEA for colorectal cancer.
